Cove Capital Investments Fully Subscribes Its Debt-Free Cove Texas Net Lease 63 Delaware Statutory Trust Offering in Lewisville, TX
Cove Capital announces another fully subscribed DST offering on behalf of accredited investors, broker-dealers, RIA’s, and registered representatives. LOS ANGELES, Feb. 7, 2024 /PRNewswire/ — Cove Capital Investments, LLC, a Delaware Statutory Trust sponsor company that specializes in p
Cogent Communications to Host Fourth Quarter and Full Year 2023 Earnings Call on February 29, 2024
WASHINGTON, Feb. 7, 2024 /PRNewswire/ — Cogent Communications Holdings, Inc. (“Cogent”) (NASDAQ: CCOI) will host a conference call at 8:30 a.m. (ET) on February 29, 2024 to present Cogent’s operating results for the fourth quarter and full year of 2023 and answer questions. C
MSA Safety Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
PITTSBURGH, Feb. 7, 2024 /PRNewswire/ — MSA Safety Incorporated (NYSE: MSA), the global leader in the development, manufacture and supply of safety products and software that protect people and facility infrastructures, today announced that it will host the company’s fourth quarter and f
Deep Indian Kitchen Launches Kati Street Wraps, An Indian Street Cart Experience
New Frozen Products Deliver Toasted Texture & Vibrant Flavors in 2 Minutes UNION, N.J., Feb. 7, 2024 /PRNewswire/ — Deep Indian Kitchen, the restaurant-quality, frozen Indian food brand recently named one of America’s fastest-growing emerging brands1, is thrilled to announce the nat
Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators
Reqorsa® Therapy May Be Potential Treatment for ALK-Positive Lung Cancer Three Collaborators Selected to Present Positive Nonclinical Data on Genprex Oncology Program at the 2024 American Association for Cancer Research (AACR) Annual Meeting AUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ — Genprex
Ophthalmology innovations paving the way for diagnosis & treatment of age-related macular degeneration (AMD)
Artificial intelligence (AI) is being developed to detect AMD disease and those who have the highest risk of progression, which may help increase the ability of people to be screened without overwhelming the healthcare system.New drugs for wet AMD, such as Faricimab (Vabysmo), which has recently b
Alan AI Assessed “Awardable” for Department of Defense Work in the CDAO’s Tradewinds Solutions Marketplace
SUNNYVALE, Calif., Feb. 7, 2024 /PRNewswire/ — Alan AI, a pioneer in leveraging Generative AI technology to revolutionize user interactions within enterprise applications, today announced that it has achieved “Awardable” status through the Chief Digital and Artificial Intelligence
Standard Motor Products’ Emission Control Program Expands
Key Takeaways Standard’s Emission Control program features more than 3,500 parts, including EVAP, EGR, and positive crankcase ventilation productsSMP manufactures emission control components in its own North American facilities located in South Carolina, Kansas, and MexicoStandard® is committ
VIVOTEK Launches “Safety Map” Campaign for the Third Consecutive Year, Embarking on a Sustainable Path Beyond the Security Field
TAIPEI, Feb. 7, 2024 /PRNewswire/ — VIVOTEK (3454-TW), the global leading IP surveillance solution provider, has been leveraging its surveillance expertise for three consecutive years, actively participating in social initiatives. This year, VIVOTEK ventured into school campuses for the first
Groundfloor announces 2023 results, surpassing $1.3 billion in retail investments and $1.1 billion investor repayments
Despite high interest rates, platform revenue grew 25% with launch of several new alternative real estate investment products ATLANTA, Feb. 7, 2024 /PRNewswire/ — Groundfloor, the award-winning alternative investment platform with over $1 billion in investment and repayment volume, is announc
